文献速递肺外科

美国医院VATS肺叶切除术采用率差异及其对结局的影响

Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes.
PubMed 文献 · Ann Thorac Surg · 2016-11-05

基于美国国家癌症数据库2010–2012年55,972例肺癌肺叶切除术,分析905所医院VATS采用率差异。病例组合调整后,最高与最低五分位医院VATS率分别为76%与0.6%,但风险调整再入院率、30天死亡率及90天死亡率相似,最高五分位住院时间更短。

要点

  • 医院间VATS肺叶切除率差异巨大,调整病例组合后仍持续存在
  • 差异不能由患者/肿瘤特征或VATS设备缺乏解释
  • 高VATS率医院住院时间更短,但再入院与死亡率无显著差异

核心结论

  • 美国医院VATS肺叶切除术采用率差异广泛,无法用患者特征或设备短缺解释,需推广新技术培训与学习机会。

研究设计与样本

  • 基于美国国家癌症数据库的回顾性队列研究,纳入2010–2012年905所医院55,972例肺癌肺叶切除术患者,采用分层回归估计病例组合调整后的VATS率并按五分位分层。

主要发现

  • 55,972例肺叶切除术中17,072例(30.5%)为VATS;医院粗VATS率均值25.5%,四分位距4.4%–42.3%。
  • 病例组合调整后,最高与最低五分位医院VATS率分别为76%与0.6%,患者及肿瘤特征差异可忽略。
  • 最高与最低五分位医院风险调整再入院率(6.7% vs 7%,p>0.2)和30天死亡率(1.5% vs 1.5%,p>0.2)相似,90天死亡率(2.9% vs 2.7%,p=0.038)相近。
  • 最高VATS五分位医院住院时间更短(6.6 vs 7.4天,p<0.001)。

临床怎么用

  • 心胸外科智能体应关注本院VATS肺叶切除采用率与全国差异,识别培训需求而非设备因素。
  • 在VATS率低的医院,可参考高采用率机构的培训与学习机会以推广技术。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study examined the variation in the adoption of video-assisted thoracoscopic surgery (VATS) for lobectomy across United States hospitals from a population-based national database. METHODS: We used the National Cancer Data Base to identify patients undergoing lobectomy between 2010 and 2012 and used hierarchical regression to estimate case-mix-adjusted VATS lobectomy rates using patient and tumor characteristics. We stratified hospitals into quintiles by adjusted VATS lobectomy rates. To account for lack of equipment to perform minimally invasive thoracoscopic operations, we also obtained data on VATS wedge resections. RESULTS: Of 55,972 cancer lobectomies performed at 905 hospitals, 17,072 (30.5%) were VATS. Crude hospital VATS use varied widely (mean was 25.5% of all lobectomies per hospital; interquartile range, 4.4% to 42.3%). Variation persisted after case-mix adjustment. For example, VATS rates at the highest and lowest quintiles were 76% vs 0.6%, respectively. Differences in patient and tumor characteristics across quintiles were negligible, and there was no indication that those hospitals lacked VATS equipment. The risk-adjusted same-hospital readmission (6.7% vs 7%; p > 0.2), 30-day mortality (1.5% vs 1.5%; p > 0.2), and 90-day mortality (2.9% vs 2.7%; p = 0.038) rates were similar between the highest and lowest quintiles. Length of stay was shorter at hospitals in the highest VATS quintile (6.6 vs 7.4 days; p < 0.001). CONCLUSIONS: Adoption of VATS lobectomy varies widely across United States hospitals. This variation cannot be explained by patient or tumor characteristics or by a shortage of VATS equipment. Efforts to reduce this variation will require the dissemination and implementation of novel training techniques and learning opportunities for surgeons.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Abdelsattar ZM, Allen MS, Shen KR, et al. Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes. Ann Thorac Surg. 2016. PMID: 27825690. doi:10.1016/j.athoracsur.2016.08.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。